Literature DB >> 15300908

Inhibition of mouse hepatocyte apoptosis via anti-Fas ribozyme.

Min Zhang1, Wei He, Fang Liu, Ping Zou, Juan Xiao, Zhao-Dong Zhong, Zhong-Bo Hu.   

Abstract

AIM: To investigate the effects of anti-Fas ribozyme on Fas expression and apoptosis in primary cultured mouse hepatocytes.
METHODS: Mouse hepatocytes were isolated by using collagenase irrigation. A hammerhead ribozyme targeting the Fas mRNA was constructed, and transfected into mouse hepatocytes via Effectene. Then Fas expression in mouse hepatocytes was detected by RT-PCR and western blotting. After being treated with anti-Fas antibody (JO2), hepatocytes viability was measured with MTT assay. Caspase-3 proteolytic activity was detected, and cell apoptosis was measured according to Annexin V-FITC apoptosis detection kit.
RESULTS: Fas expressed in primary mouse hepatocytes. Fas expression in hepatocytes transfected with anti-Fas ribozyme was decreased remarkably and correlated with the resistance to Fas-mediated apoptosis as determined by flow cytometry and caspase-3 proteolytic activity.
CONCLUSION: Anti-Fas ribozyme can remarkably decrease the Fas expression in mouse hepatocytes, thus inhibit Fas-mediated apoptosis in hepatocytes. It is suggested that anti-Fas ribozyme could significantly increase the resistance of transplanted hepatocytes to apoptosis and improve the survival of transplanted hepatocytes. Copyright 2004 The WJG Press ISSN

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300908      PMCID: PMC4572165          DOI: 10.3748/wjg.v10.i17.2567

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Assessment of ribozyme cleavage efficiency using reverse transcriptase real-time PCR.

Authors:  D Klein; M Denis; C Ricordi; R L Pastori
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

2.  Involvement of the Fas system in liver allograft rejection.

Authors:  M Rivero; J Crespo; M Mayorga; E Fábrega; F Casafont; F Pons-Romero
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

Review 3.  Ribozymes: a modern tool in medicine.

Authors:  Asad U Khan; Sunil K Lal
Journal:  J Biomed Sci       Date:  2003 Sep-Oct       Impact factor: 8.410

4.  New hepatic vein reconstruction by double expansion of outflow capacity of left-sided liver graft in living-donor liver transplantation.

Authors:  Yoshinobu Sato; Satoshi Yamamoto; Toshiyuki Takeishi; Hideki Nakatsuka; Hidenaka Kokai; Katsuyoshi Hatakeyama
Journal:  Transplantation       Date:  2003-09-15       Impact factor: 4.939

5.  A helical twist-induced conformational switch activates cleavage in the hammerhead ribozyme.

Authors:  Christine M Dunham; James B Murray; William G Scott
Journal:  J Mol Biol       Date:  2003-09-12       Impact factor: 5.469

6.  Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.

Authors:  Hideaki Uchiyama; Kenji Kishihara; Ryosuke Minagawa; Koji Hashimoto; Keizo Sugimachi; Kikuo Nomoto
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

Review 7.  US of liver transplants: normal and abnormal.

Authors:  Jane D Crossin; Derek Muradali; Stephanie R Wilson
Journal:  Radiographics       Date:  2003 Sep-Oct       Impact factor: 5.333

8.  Successful conservative management of acute hepatic failure following exertional heatstroke.

Authors:  Martin Wagner; Peter Kaufmann; Peter Fickert; Michael Trauner; Carolin Lackner; Rudolf E Stauber
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-10       Impact factor: 2.566

9.  Effects of middle hepatic vein reconstruction on right liver graft regeneration.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Junichi Kaneko; Keiji Sano; Hiroshi Imamura; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Transplantation       Date:  2003-09-15       Impact factor: 4.939

10.  Resistance to Fas-induced apoptosis in hepatocytes: role of GSH depletion by cell isolation and culture.

Authors:  Lina Musallam; Chantal Ethier; Pierre Selim Haddad; Francine Denizeau; Marc Bilodeau
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-09       Impact factor: 4.052

View more
  3 in total

1.  Recombinant adenovirus containing hyper-interleukin-6 and hepatocyte growth factor ameliorates acute-on-chronic liver failure in rats.

Authors:  Dan-Dan Gao; Jia Fu; Bo Qin; Wen-Xiang Huang; Chun Yang; Bei Jia
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

2.  Establishment and Characterization of an In Vitro Model of Fas-Mediated Hepatocyte Cell Death.

Authors:  Mathieu Vinken; Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Tamara Vanhaecke; Vera Rogiers
Journal:  Methods Mol Biol       Date:  2015

3.  Gene delivery to pancreatic exocrine cells in vivo and in vitro.

Authors:  Isabelle Houbracken; Luc Baeyens; Philippe Ravassard; Harry Heimberg; Luc Bouwens
Journal:  BMC Biotechnol       Date:  2012-10-22       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.